1017TiP KEYNOTE-937 trial in progress: adjuvant pembrolizumab in patients with hepatocellular carcinoma (HCC) and complete radiologic response after surgical resection or local ablation
Arndt Vogel, Andrew X. Zhu, Ann‐Lii Cheng, Thomas Yau, Jian Zhou, E. Kim, Usha Malhotra, A.B. Siegel, Masatoshi Kudo
Topics & Concepts
MedicinePembrolizumabTolerabilitySorafenibHepatocellular carcinomaSurgeryPlaceboClinical endpointResponse Evaluation Criteria in Solid TumorsInternal medicineRandomized controlled trialAdverse effectOncologyClinical trialCancerPhases of clinical researchPathologyImmunotherapyAlternative medicinePancreatic and Hepatic Oncology ResearchHepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies